Language

News topic

Expected end: 2027-12

All current shortage notices related to Expected end: 2027-12, structured by product, country, active ingredient and reporting period.

17 notices

← All shortages

Germany

Bisoprolol Accord 5 mg Filmtabletten

Active ingredient: Bisoprololfumarat (Ph.Eur.)

View notice details →
Germany

Bisoprolol Accord 2,5 mg Filmtabletten

Active ingredient: Bisoprololfumarat (Ph.Eur.)

View notice details →
Germany

Bisoprolol Accord 10 mg Filmtabletten

Active ingredient: Bisoprololfumarat (Ph.Eur.)

View notice details →
Germany

OncoTICE

Active ingredient: BCG-Bakterien, Stamm TICE, lebend, attenuiert

View notice details →
Czechia

XALOPTIC COMBI 0,05MG/ML+5MG/ML OPH GTT SOL 3X2,5ML

Active ingredient: TIMOLOL, KOMBINACE

View notice details →
Belgium

Matrifen 12 µg/h transderm. patch sachet 2 (1,38 mg/4,2 cm²)

Active ingredient: Fentanyl

View notice details →
Belgium

Nexviadyme 100 mg inj. sol. (pwdr., conc.) i.v. vial 5 x 100 mg

Active ingredient: Avalglucosidase Alfa

View notice details →
Belgium

Nexviadyme 100 mg inj. sol. (pwdr., conc.) i.v. vial 10 x 100 mg

Active ingredient: Avalglucosidase Alfa

View notice details →
Germany

ARA-cell 100 mg/ml Konzentrat zur Herstellung einer Infusionslösung

Active ingredient: Cytarabin

View notice details →
Germany

IFO-cell 5 g Konzentrat zur Herstellung einer Infusionslösung

Active ingredient: Ifosfamid

View notice details →
Germany

IFO-cell 2g Konzentrat zur Herstellung einer Infusionslösung

Active ingredient: Ifosfamid

View notice details →

Plan supply. Connect sourcing and warehousing.

For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.